Trials / Unknown
UnknownNCT04808674
Remediation for Mild Cognitive Deficits After Cancer
EvalUation of REmediation Programs for Patients Suffering From Mild Cognitive Deficits After CAncer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cancer survival rates have improved significantly over the past decades and patients now experience a number of side effects including cancer-related cognitive impairment (CRCI): problems with memory, executive function, attention, and difficulties performing two tasks at the same time. The frequency of CRCI in cancer patients is estimated to be between 10 to 40%, and more than 50% of patients describe difficulties in their daily life. These cognitive difficulties negatively impact the patient's quality of life as well as that of their family, and can also have negative consequences for their social and professional reintegration once cancer treatment is finished. Despite an increasing number of studies on CRCI, a standard of care for patients with CRCI after breast cancer is yet to be established. In the absence of clear directives, and in an attempt to respond to the increasing demand to provide care for breast cancer patients with CRCI, physical medicine and rehabilitation units in France have started providing day-hospital multidisciplinary interventions. The objective of this project is to use the single case experimental design method to investigate the efficacy of two such rehabilitation programs: a group-based program and a one-on-one program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive remediation program | Evaluation of REmediation programs for patients suffering from mild cognitive deficits after Cancer |
Timeline
- Start date
- 2021-12-17
- Primary completion
- 2025-07-17
- Completion
- 2025-07-17
- First posted
- 2021-03-22
- Last updated
- 2023-01-13
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04808674. Inclusion in this directory is not an endorsement.